The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2015 ACR/ARHP Annual Meeting: RA Pathogenesis and Prevention

2015 ACR/ARHP Annual Meeting: RA Pathogenesis and Prevention

February 17, 2016 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“I expect that the next generation of rheumatologists will experience dramatic changes in the way that RA is evaluated and treated, with an increasing focus on screening and prevention and the identification of novel therapeutic targets and strategies in the preclinical period,” said Dr. Holers. “Consider how cardiovascular disease prevention has evolved over the last 30 years, and expect the same in RA and other rheumatologic and autoimmune diseases.”

You Might Also Like
  • 2015 ACR/ARHP Annual Meeting: Research Offers Clues to Environmental Triggers of RA
  • 2015 ACR/ARHP Annual Meeting: Better Pain Prevention, Treatment Needed for Older Adults
  • 2015 ACR/ARHP Annual Meeting: Unknowns Persist Around Sarcoidosis Etiology, Pathogenesis, Treatment
Explore This Issue
February 2016
Also By This Author
  • ACR Continues to Press CMS to Make Changes to E/M Codes

Mary Beth Nierengarten is a freelance medical journalist based in St. Paul, Minn.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Second Chance

If you missed this session, it’s not too late. Catch it on SessionSelect.

References

  1. Sokolove J, Bromber R, Deane KD, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression. PLoS ONE. 2012;7(5):335296.
  2. Gan RW, Trouw LA, Shi J, et al. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. J Rheumatol. 2015;42(12).
  3. Kolfenbach JR, Deane KD, Derber LA, et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis using first-degree relatives of probands with RA. Arthritis Rheum. 2009;61(12):1735–1742.
  4. Bhatia SS, Majka DS, Kittelson JM, et al. Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis. Ann Rheum Dis. 2007;66(2):267–269.
  5. Feser M, Derber LA, Deane KD, et al. Plasma 25, OH vitamin D levels are not associated with rheumatoid arthritis-related autoantibodies in individuals at elevated risk for rheumatoid arthritis. J Rheumatol. 2009;36(5):943–946.
  6. Gan RW, Deane KD, Zerbe GO, et al. Relationship between air pollution and positivity of ra-related autoantibodies in individuals without established RA: A report on SERA. Ann Rheum Dis. 2013;72(12).
  7. Norris JM, Gan RW, Hughes-Austin JM, et al. Lack of association between preclinical markers for cardiovascular disease and rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis. American College of Rheumatology 2013 Meeting Abstract #116.
  8. Gan RW, Young KA, Zerbe GO, et al. Lower omega-3 fatty acids are associated with the presence of anti-cycliccitrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: A nested case-control study. rheumatology 2015 Sep 13. pii: kev266. [Epub ahead of print].
  9. Gan RW, Demoruelle MK, Deane KD, et al. Omega-3 fatty acids are associated with a lower prevalence of autoantibody positivity in HLA-DR shared epitope positive subjects who are at increased risk for future RA. American College of Rheumatology 2013 Meeting Abstract #2021
ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: 2015 ACR/ARHP Annual Meeting, American College of Rheumatology, Cause, environmental, genetic, Pathogenesis, pathway, prevent, Research, Rheumatoid arthritis, triggersIssue: February 2016

You Might Also Like:
  • 2015 ACR/ARHP Annual Meeting: Research Offers Clues to Environmental Triggers of RA
  • 2015 ACR/ARHP Annual Meeting: Better Pain Prevention, Treatment Needed for Older Adults
  • 2015 ACR/ARHP Annual Meeting: Unknowns Persist Around Sarcoidosis Etiology, Pathogenesis, Treatment
  • 2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)